Patients with PH-ILD are categorized as group 4 PH. Regrettably, there aren’t many approved treatment options for this group of PH patients. In this detailed and advanced talk, Dr. Rahaghi presents the prevalence and extent of PH in ILD patients, explains how to recognize PH in ILD patients, and reviews the current treatment options.
Advocacy
PH Toolkit presentation
| Presenter: | The Health Policy Partnership presents |
|---|---|
| Presentation date: | November 2024 |
| Length: | 32 minutes |
| Q&A: | Yes |
| Difficulty level (1-5): | 1 |
| Subtitled: | No |
| Dubbing: | No |
| Tag(s): | Patient tools, Advocacy |
BAC Admin
November 19, 2024
